Guizhen Wu to Pandemics
This is a "connection" page, showing publications Guizhen Wu has written about Pandemics.
Connection Strength
0.037
-
Excretion of SARS-CoV-2 through faecal specimens. Emerg Microbes Infect. 2020 Dec; 9(1):2501-2508.
Score: 0.008
-
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2. Cell. 2020 08 06; 182(3):713-721.e9.
Score: 0.007
-
Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2. Science. 2020 05 29; 368(6494):1016-1020.
Score: 0.007
-
One Hundred Days of Coronavirus Disease 2019 Prevention and Control in China. Clin Infect Dis. 2021 01 27; 72(2):332-339.
Score: 0.002
-
Immune suppression in the early stage of COVID-19 disease. Nat Commun. 2020 11 17; 11(1):5859.
Score: 0.002
-
Morphogenesis and cytopathic effect of SARS-CoV-2 infection in human airway epithelial cells. Nat Commun. 2020 08 06; 11(1):3910.
Score: 0.002
-
Single-Cell Sequencing of Peripheral Mononuclear Cells Reveals Distinct Immune Response Landscapes of COVID-19 and Influenza Patients. Immunity. 2020 09 15; 53(3):685-696.e3.
Score: 0.002
-
A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2. Nature. 2020 08; 584(7819):120-124.
Score: 0.002
-
A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2. Science. 2020 06 12; 368(6496):1274-1278.
Score: 0.002
-
Detection of SARS-CoV-2 in Different Types of Clinical Specimens. JAMA. 2020 05 12; 323(18):1843-1844.
Score: 0.002
-
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice. Nature. 2020 07; 583(7818):830-833.
Score: 0.002